15 studies found for:    PN400
Show Display Options
Rank Status Study
1 Completed
Has Results
A 12-month, Phase 3, Open-label, Multi-center Study to Evaluate the Long-term Safety of PN400 (VIMOVO)
Condition: Gastric Ulcer
Interventions: Drug: PN400 (VIMOVO);   Drug: PN 400 (VIMOVO)
2 Completed Study Evaluating the Effect of Food on the Bioavailability of PN400 Components
Condition: Arthritis
Intervention: Drug: PN400
3 Completed
Has Results
Efficacy Study of PN400 (VIMOVO) Twice Daily and Celebrex Once Daily in Patients With Osteoarthritis
Condition: Osteoarthritis
Interventions: Drug: PN 400 (VIMOVO);   Drug: celebrex;   Drug: Placebo;   Drug: Rescue Antacid
4 Completed
Has Results
Efficacy Study of PN400 (VIMOVO) Twice Daily and Celebrex Once Daily in Patients With Osteoarthritis
Condition: Osteoarthritis
Interventions: Drug: PN 400 (VIMOVO);   Drug: celebrex;   Other: Placebo;   Drug: Rescue Antacid
5 Completed PK Study to Evaluate Esomeprazole Plasma Levels Following Administration of PN 400
Condition: Healthy
Intervention: Drug: PN400
6 Terminated
Has Results
Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers in High Risk Subjects Compared to Arthrotec
Condition: Gastric Ulcer
Interventions: Drug: PN400 (VIMOVO);   Drug: Diclofenac/Misoprostol
7 Completed
Has Results
Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers Compared to Non-steroidal Antiinflammatory Drug (NSAID) Naproxen
Condition: Gastric Ulcer
Interventions: Drug: PN400 (VIMOVO);   Drug: Naproxen
8 Completed
Has Results
Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers Compared to Non-steroidal Antiinflammatory Drug (NSAID) Naproxen
Condition: Gastric Ulcer
Interventions: Drug: PN400 (VIMOVO);   Drug: Naproxen
9 Completed Comparison Study of a New Combination of 2 Marketed Medications (Esomeprazole and Naprosyn) Versus Naprosyn Alone
Condition: Healthy
Interventions: Drug: PN400;   Drug: Naprosyn
10 Completed Phase I Study to Evaluate Bioavailability of Naproxen as PN400 Compared to Naproxen as Naprosyn E
Condition: Healthy
Interventions: Drug: PN400;   Drug: Naproxen
11 Completed A Study Assessing Inhibition of Serum Thromboxane B2 Levels With PN400 and Low Dose Aspirin
Condition: Platelet Inhibition
Interventions: Drug: PN400;   Drug: ASA;   Drug: Placebo
12 Completed A Pharmacokinetic (PK) Study Evaluating Naproxen and Esomeprazole Plasma Levels
Condition: Arthritis
Interventions: Drug: PN 400;   Drug: EC naproxen plus EC esomeprazole;   Drug: EC naproxen;   Drug: EC esomeprazole
13 Completed Phase I Study to Evaluate Bioavailability of Naproxen as PN400 Compared to Naproxen as Proxen S and Naprosyn E
Condition: Healthy Volunteer
Interventions: Drug: PN400;   Drug: Naproxen (Proxen S);   Drug: Naproxen (Naprosyn E)
14 Completed Study Evaluating the Bioavailability of Naproxen 500 mg in Three Formulations
Condition: Arthritis
Interventions: Drug: PN400;   Drug: naproxen
15 Completed Study Evaluating the Bioavailability of Naproxen 375 mg in Two Formulations
Condition: Arthritis
Interventions: Drug: PN400;   Drug: Naproxen

Indicates status has not been verified in more than two years